Zydus Lifesciences concludes subject enrolment in Phase II ALS trial
Zydus Lifesciences has announced the conclusion of subject enrolment in the Phase II clinical trial of Usnoflast (ZYIL1) to treat…
Zydus Lifesciences has announced the conclusion of subject enrolment in the Phase II clinical trial of Usnoflast (ZYIL1) to treat…
GlycoMimetics has reported positive initial data from a Phase Ia clinical trial of its E-selectin antagonist, GMI-1687, to potentially treat…
South Korean biotechnology company PharmAbcine has published preclinical research demonstrating the potential of PMC-403, its Tie2-activating antibody programme. PMC-403 has…
Walgreens has announced a partnership with the Cardiovascular Research Foundation (CRF) for the PREVUE-VALVE population-based clinical trial. Aimed at quantifying…
IMUNON has started treating the first patient in a Phase I/II clinical trial of IMNN-001, along with bevacizumab in advanced…
SynAct Pharma has reported that the P2b EXPAND study of oral resomelagon (AP1189) to treat rheumatoid arthritis (RA) patients failed…
NextPoint Therapeutics has announced the dosing of the first subject with NPX267 in a trial to treat patients with solid…
Researchers at the University of the Sunshine Coast (UniSC) in Australia have announced plans to commence a trial of a…
Lindus Health has raised $18m in a Series A funding round to scale up and continue executing its end-to-end clinical…
Alphabet precision health technology company Verily and OneOncology have announced a strategic collaboration for clinical trials. Under the partnership, community…